Michelle Ross
CIO of StemPoint Capital, a biotech and healthcare-focused investment firm. She discusses healthcare stocks and potential executive orders on pricing.
Best podcasts with Michelle Ross
Ranked by the Snipd community
May 9, 2025 • 43min
Closing Bell: 5/9/25
Michelle Ross, CIO of StemPoint Capital and expert in biotech investments, shares insights on the evolving healthcare landscape. She tackles the complexities of drug pricing in the U.S., balancing innovation with affordability. The discussion highlights potential regulatory changes affecting investor sentiment and market dynamics. Ross also explores exciting investment opportunities in rare diseases and oncology firms while examining the impact of upcoming FDA approvals on stock performance.
